Drug Repurposing News and Research

RSS
Azelastine nasal spray could decrease SARS-CoV-2 load

Azelastine nasal spray could decrease SARS-CoV-2 load

British Heart Foundation funded Surrey project will address cardiac safety in novel anti-malarial agents

British Heart Foundation funded Surrey project will address cardiac safety in novel anti-malarial agents

What is the role of a niclosamide-based organic/inorganic hybrid in the suppression of SARS-CoV-2 infections?

What is the role of a niclosamide-based organic/inorganic hybrid in the suppression of SARS-CoV-2 infections?

Bisphosphonates appear to improve COVID-19 exposure outcomes

Bisphosphonates appear to improve COVID-19 exposure outcomes

Novel approach to drug repurposing incorporates two-stage prediction and machine learning

Novel approach to drug repurposing incorporates two-stage prediction and machine learning

Identifying new chemicals with greater effectiveness, safety than quisinostat

Identifying new chemicals with greater effectiveness, safety than quisinostat

Study explores SARS-CoV-2 RNA genome's functional interactions with host cell

Study explores SARS-CoV-2 RNA genome's functional interactions with host cell

The potency of halicin against the main protease of SARS-CoV-2

The potency of halicin against the main protease of SARS-CoV-2

Certain antirheumatic drugs may lower incidence of Alzheimer's and related dementias in people with cardiovascular disease

Certain antirheumatic drugs may lower incidence of Alzheimer's and related dementias in people with cardiovascular disease

High-throughput screening assay could identify new prostate cancer drugs

High-throughput screening assay could identify new prostate cancer drugs

Study investigates targeted phenotyping of host proteins aiding drug repurposing in COVID-19

Study investigates targeted phenotyping of host proteins aiding drug repurposing in COVID-19

CDK6: a potential drug target for severe COVID-19

CDK6: a potential drug target for severe COVID-19

Study finds methylene blue is a low-micromolar inhibitor of the the SARS-CoV-2 spike protein and ACE2 interaction

Study finds methylene blue is a low-micromolar inhibitor of the the SARS-CoV-2 spike protein and ACE2 interaction

Study unveils several natural marine products as potential agents against SARS-CoV-2

Study unveils several natural marine products as potential agents against SARS-CoV-2

Study reports thiopurines inhibit the replication of the betacoronaviruses HCoV-OC43 and SARS-CoV-2

Study reports thiopurines inhibit the replication of the betacoronaviruses HCoV-OC43 and SARS-CoV-2

In silico screening and testing of FDA approved drugs inhibiting SARS-CoV-2 spike protein cleavage

In silico screening and testing of FDA approved drugs inhibiting SARS-CoV-2 spike protein cleavage

Exploring biomedical literature and clinical trial records to identify new drug combinations for COVID-19 treatment

Exploring biomedical literature and clinical trial records to identify new drug combinations for COVID-19 treatment

What does the Future of Artificial Intelligence Look Like within the Life Sciences?

What does the Future of Artificial Intelligence Look Like within the Life Sciences?

Screening assays identify TMPRSS2 inhibitors from drug repurposing candidates useful as COVID-19 therapeutic

Screening assays identify TMPRSS2 inhibitors from drug repurposing candidates useful as COVID-19 therapeutic

Study finds limited evidence for IL-1 blockers in treating COVID-19

Study finds limited evidence for IL-1 blockers in treating COVID-19